Miami Eye & Retina
The premier ophthalmology practice in Miami Beach

Our team is dedicated to providing the finest possible care by utilizing breakthrough advances and techniques in the field of ophthalmology. Miami Eye & Retina has the latest generation cutting edge technology to improve diagnostic precision and improve patient comfort. Our practice prides itself on our personalized care, minimal wait lines, modern equipment, and operational efficiency.

Daniel Gologorsky, MD, MBA is the Chief of Ophthalmology at Mount Sinai Medical Center in Miami Beach. He is a board-certified Ophthalmologist and fellowship-trained Retina specialist who takes compassionate care of patients with all types of eye disease, including diabetic retinopathy, macular degeneration, glaucoma, cataract, uveitis, and dry eye. Dr. Gologorsky is a published textbook author and prolific academic who has lectured nationally and internationally on ophthalmic imaging and lasers. A native of Miami Beach, Dr. Gologorsky enjoys Roman history, playing chess, kayaking, and biking.

Expertise

We offer expert medical and surgical treatments for the following conditions:
Annual Eye Exams
Diabetic Retinopathy
Macular Degeneration
Glaucoma
Dry Eye
Cataract
HIV Retinopathy
Retinal tears / detachments
Blepharitis
Presbyopia
Plaquenil
Macular Edema
Vascular Disease
Vitreous Hemorrhage
Uveitis
Optic Neuropathy
Chalazion / Stye
Trauma

Education

Education & Training

  1. Cornell University (BA)

    Chemistry & Chemical Biology major. Graduated magna cum laude, Phi Beta Kappa, 4.0 GPA.

  2. Dartmouth Medical School (MD)

    Recipient of the Douglas P. Zipes MD Award for Excellence in Medical Research.

  3. Tuck School of Business at Dartmouth (MBA)

    Focusing on healthcare delivery and operations management. Recipient of the Campers, Payson, and Wilson Family Award.

  4. Bascom Palmer Eye Institute

    Ophthalmology residency at the top ranked ophthalmology program in the USA. Recipient of the American Society of Cataract and Refractive Surgeons Foundation Award.

  5. New York Eye & Ear Infirmary

    Fellowship in diseases of the retina and vitreous.

Professional Affiliations

  1. American Academy of Ophthalmology (AAO)

  2. American Society of Retina Specialists (ASRS)

Textbook

Gologorsky D, Rosen RB. Principles of Ocular Imaging

Gologorsky D, Rosen RB.Principles of Ocular Imaging.Thorofare, NJ: SLACK, Inc.; 2021.

Dr. Gologorsky is coauthor of Principles of Ocular Imaging, a definitive and comprehensive guide of all current ocular imaging modalities used in ophthalmology. This textbook is used extensively in ophthalmology and optometry residency training programs throughout the United States.

Publications

Selected PubMed Manuscripts

  1. 1. Osigian CJ, Gologorsky D, Cavuoto KM, Berrocal A, Villegas V. Oral aceta zolamide as a medical adjuvant to retinal surgery in optic disc pit maculopathy in a pediatric patient. Am J Ophthalmol Case Rep. 2020 Jan 16;17:
  2. 2. Kaplan RI, Drinkwater OJ, Lee RH, Chod RB, Barash A, Giovinazzo JV,Gologorsky D , Jansen ME, Rosen RB, Gentile RC. Pain Control after Intravitreal Injection Using Topical Nepa fenac 3% or Pressure Patching: A Randomized, Placebo-Controlled Trial. Ophthalmol Retina. 2019 Apr
  3. 3. Gologorsky D. Eponymous Dishonor: Kyrielies Plaques. Retina. 2018 Jul;38(7):1261-
  4. 4. Gologorsky D , Rosen R, Lee J. Navigated Retina Laser Therapy (Navilas) as a novel method of laser retinopexy for retinal tears. OSLI-Retina 2018 Nov 1;49(11):e206-e209
  5. 5. Spierer O, Gologorsky D , Adler E, Forster RK. Lamellar keratoplasty with corneoscleral graft for limbal dermoids. Int J Ophthalmol. 2018 Mar 18;11(3):512-
  6. 6. Gologorsky D , Spierer O. Asteroid Hyalosis. Eur J Intern Med, May 2017
  7. 7. Gologorsky D, Williams BK, and Flynn HW Jr. Posterior Pole Retinal Detachment Due to a Macular Hole in a Patient with a Boston Keratoprosthesis. American Journal of Ophthalmology. 2016 April; 5:56-58
  8. 8. Gologorsky D and Flynn HW Jr. Cataract Surgery in the Setting of Severe Pathologic Myopia with High Axial Length: Use of Pars Plana Lensectomy and Vitrectomy. Clin Ophthalmol. 2016 May 27;10:989-
  9. 9. Gologorsky D , Gregori N, Goldhardt R. Dermatologic and Retinal Manifestations of Pseudoxanthoma Elasticum. Br J Dermatol. 2016 Apr;174(4):e21
  10. 10 .Sridhar J, Isom RF, Gologorsky D , Schiffman J, Ajuria L, Huang L , Banta JT. Utilization of Ophthalmology-Specific Emergency Department Services. Semin Ophthalmol. 2016 Sep 6:1- Gologorsky D
  11. 11. Spierer O, Monsalve PF, O’Brien TP, Alfonso EC,Gologorsky D , Miller D. Clinical features, antibiotic
  12. 12. susceptibility profiles, and outcomes of infectious keratitis caused by Achromobacter xylosoxidans. Cornea.2016 May;35(5):626-
  13. 13. Gologorsky D . A Piece of my Mind. On Vision and Perception. JAMA. 2014 Feb 19;311(7):675-6
  14. 14. Gologorsky D , Murray TG. Letter to the editor: immediate implications of improved surgical efficiency. Clin Ophthalmol. 2013;7:2287-8
  15. 15. Gologorsky D , Chang JS, Hess DJ, Berrocal AM. Familial Exudative Vitreoretinopathy in a Premature Child. Ophthalmic Surgery, Lasers & Imaging – Retina. 2013 Nov 1;44(6):603-5
  16. 16. Brodt J, Gologorsky D , Walter S, Pham SM, Gologorsky E. Orbital Compression Syndrome Following Extracorporeal Support. Journal of Cardiac Surgery. 2013 Sep;28(5):522-4
  17. 17. Schefler AC, Gologorsky D , Marr BP, Shields CL, Zeolite I, Abramson DH. Extraocular Metastases of Choroidal Melanoma After Invasive Diagnostic Evaluation. JAMA Ophthalmol. 2013 Sep;131(9):1220-42
  18. 18. Gologorsky D , Greenstein SH. Retrospective Analysis of Second Opinion Patients Self-Referred to Comprehensive Ophthalmology. (Journal of Clinical Ophthalmology. 2013 June. 2013;7:1099 –
  19. 19. Gologorsky D, Jakobiec FA, Freitag S. Transconjunctival Elimination of a Meibomian Keratinous Cyst. Ophthalmic Plastic and Reconstructive Surgery. Ophthalmic Plastic & Reconstructive Surgery. 2012 Dec
  20. 20. Hemmati HD, Gologorsky D , Pineda R. Intraoperative Wavefront Aberrometry in Cataract Surgery. Seminars in Ophthalmology. Seminars in Ophthalmology. 2012 Sep-Nov;27(5-6):100-
  21. 21. Murray TG, Layton AJ, Tong KB, Gittelman M,Gologorsky D , Vigoda M. Transition to a novel advanced integrated vitrectomy platform: Comparison of surgical impact of moving from the Accurus to the Constellation Vision System. Journal of Clinical Ophthalmology. 2013;7:367-
  22. 22. Gologorsky D , Thanos A, Vavvas D. Therapeutic Interventions against Inflammatory and Angiogenic Mediators in Proliferative Diabetic Retinopathy. Mediators of Inflammation. 2012; 2012: 629452
  23. 23. Bekelis K, Desai A, Zhao W, Gibson D, Gologorsky D , Eskey C, Erkmen K. CT angiography: Improving diagnostic yield and cost-effectiveness in the initial evaluation of spontaneous non-subarachnoid intracerebral hemorrhage. Journal of Neurosurgery . 2012 Oct;117(4):761-
  24. 24. Khan S, Finger PT, Yu GP, Razzaq L, Jager MJ, de Keizer RJ, Sandkull P, Seregard S, Gologorsky D , Schefler AC, Murray TG, Kivelä T, Giuliari GP, McGowan H, Simpson ER, Corriveau C, Coupland SE, Damato BE. Angle involvement and glaucoma in patients with biopsy-proven iris melanoma: a response-reply. Archives of Ophthalmology. Archives of Ophthalmology. September 2012;130(9):1229-
  25. 25. Khan S, Finger PT, Yu GP, Razzaq L, Jager MJ, de Keizer RJ, Sandkull P, Seregard S, Gologorsky D , Schefler AC, Murray TG, Kivelä T, Giuliari GP, McGowan H, Simpson ER, Corriveau C, Coupland SE, Damato BE. Clinical and pathologic characteristics of biopsy-proven iris melanoma: a multicenter international study. Archives of Ophthalmology. January 2012;130(1):57-
  26. 26. Gologorsky D , Schefler AC, Williams BK, Dubovy SR, Murray TG. Medulloepithelioma: Invasive versus Noninvasive Diagnostic Methods and their Impacts on Outcome. Retinal Cases and Brief Reports, Winter
  27. 27. Piña Y, Decatur C, Murray TG, Houston SK,Gologorsky D , Cavalcante M, Cavalcante L, Hernandez H, Celdran M, Feuer W, Lampidis T. Advanced retinoblastoma treatment: targeting hypoxia by inhibition of the mammalian target of rapamycin (mTOR) in LH BETA T AG retinal tumors. Journal of Clinical Ophthalmology. March 2011;5:337–
  28. 28. Williams BK, Cebulla CM, Schefler AC, Fernandes CE,Gologorsky D , Murray TG. Required reduction in dose of chemotherapy for retinoblastoma due to Down syndrome-associated chemosensitivity. Retinal Cases and Brief Reports, Winter
  29. 29. Williams BK Jr, Schefler AC, Garonzik SN,Gologorsky D , Shi W, Cavalcante LL, et al. Frequentprosthesis refitting to prevent implant exposure in patients with retinoblastoma. Journal of Pediatric Ophthalmology and Strabismus. 2010;23:1-
  30. 30. Gologorsky D , Schefler AC, Ehlies FJ, Raskauskas PA, Williams BK, Murray TG. Clinical Imaging and High-Resolution Ultrasonography in Melanocytoma Management. Journal of Clinical Ophthalmology. 2010; 4: 855–
  31. 31. Schefler AC, Gologorsky D , Murray TG. Primary Intraocular Lymphoma: An Update on Pathology and Treatments. Retina Today, August
  32. 32. Gologorsky Y, Gologorsky D , Surti U, Yarigina A, MJ Zirwas. Karyotypic and Genetic Abnormalities in Familial Multiple Lipomatosis: A Case Report and Review of the Literature. Cutis. March 2007; 79:227-

Selected Textbook Chapters

  1. 1. Mehta N, Gologorsky D . Fluorescein Angiography" In: Retinal Imaging and Diagnostics. Lee J and Rosen RB (eds). Springer International Publishing Switzerland,
  2. 2. Gologorsky D and Mohsenin A. "Central Retinal Artery Occlusion" In: Manual of Retinal Disease. Medina CA, Townsend JH, Singh AD (eds). Springer International Publishing Switzerland,
  3. 3. Gologorsky D and Mohsenin A. "Branch Retinal Artery Occlusion" In: Manual of Retinal Disease. Medina CA, Townsend JH, Singh AD (eds). Springer International Publishing Switzerland,
  4. 4. Gologorsky D and Mohsenin A. "Cilioretinal Artery Occlusion" In: Manual of Retinal Disease . Medina CA, Townsend JH, Singh AD (eds). Springer International Publishing Switzerland,
  5. 5. Gologorsky D and Mohsenin A. "Idiopathic Juxtafoveal Telangiectasias" In: Manual of Retinal Disease. Medina CA, Townsend JH, Singh AD (eds). Springer International Publishing Switzerland,
  6. 6. Gologorsky D and Mohsenin A. "Ocular Ischemic Syndrome" In: Manual of Retinal Disease . Medina CA, Townsend JH, Singh AD (eds). Springer International Publishing Switzerland,
  7. 7. Gologorsky D and TG Murray . "Enucleation surgery in advanced ocular disease" In: Ocular Melanoma: Advances in Diagnostic and Therapeutic Strategies . Murray TG and H Culver Boldt (eds). 2013
  8. 8. Gologorsky D . "The Cornea. In: Fundamentals of Basic Science and Clinical Medicine. First edition. Providence, RI: Medectomy Publishing;
  9. 9. Gologorsky D . The Lens. In: Fundamentals of Basic Science and Clinical Medicine. First edition. Providence, RI: Medectomy Publishing;
  10. 10. Gologorsky D and AC Schefler. Ocular Oncology. In: Fundamentals of Basic Science and Clinical Medicine. First edition. Providence, RI: Medectomy Publishing;

Coronavirus transmission - through the eyes!

Posted on May 20, 2020

Several cases have been reported in the media and medical literature regarding the spread of coronavirus through the eyes. Several of my patients have asked me, "How is this possible?"

How is this possible?

The eye's defense system

The eye has a robust physical defence mechanism against the contaminated outside world.

  • First, just like the rest of the body, the eye has a "skin layer" that protects it from the contaminated outside world. This thin layer (called the conjunctiva) physically protects the eye from most contaminants.
  • Second, the eye is protected with tears, produced by the lacrimal gland and drained through the lacrimal drainage system (into the nose), to wash away any incidental germs on the surface of the eye.

coronavirus eye transmission

When the system fails

Most viruses and bacteria are introduced to the eye via touch or rubbing, but most do not cross the conjunctival barrier and are blinked away - washed out by the tears - and drained out of eye region.

But sometimes a virus or bacterium causes a local eye infection, a conjunctivitis. This is colloquially known as a "pink eye", that appears red, feels itchy, and produces a watery or purulent discharge. Most conjunctivitis infections usually resolve on their own. (In fact, most conjunctivitis infections are caused by the adenovirus, the same virus that causes an upper respiratory infection, or the common cold. So it is quite common for someone with a cold to have an eye that is inoculated wiith the same pathogen, and to develop a conjunctivitis concurrently.)

From eye to everywhere

Once the virus is in the eye, the virus can then be transmitted from the eye to the rest of the body through the mechanism we discussed earlier, the tears.

Imagine a person shakes hands with an infected individual and subsequently rubs one's eye. The virus is flushed from the eye surface wthrough the tears, which are drained through the punctum and nalolacrimal system and released into the nose!

So the virus then finds itself in nasal mucosa and the oropharaynx (the throat), where it reproduces favorably and infects the rest of the body.

Side note: this absorption mechanism through tears is why an astute ophthalmologist will ask his glaucoma patients whether or not they have a cardiac or pulmonary history prior to prescribing "eye drops", as they all have systemic absorption through this mechanism.

Keep safe

The eyes are an often overlooked mode of entry for any virus or bacterium. During the era of COVID-19, in addition to donning masks and gloves, it is essential to avoid touching ones face and rubbing one's eyes.

Contact

Contact Form